2MG-31299-13921
2 vaccinations
3 coded responses
18 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 500 / IA
- Registered
- 2021-11-07
- Relationship
- Child or adolescent in my care
- Guardian
- ZUS-14538-15879
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-06
Dose 1 — Pfizer-BioNTech
-
2021-11-07
Registered in v-safe
-
2021-11-07
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Injection site pain — Feeling: GoodFree text: She had pain at injection site the day of their shot.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
- 2021-11-11
- 2021-11-13
- 2021-11-20
- 2021-11-27
-
2021-11-30
Dose 2 — Pfizer-BioNTech
-
2021-12-01
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-03
- 2021-12-05
- 2021-12-09
-
2021-12-14
Survey response — day 14, dose 2, dependentMedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Has a cold with runny nose and cough.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
-
2022-03-01
Survey response — 3 months, dose 2, dependentMedDRA: Conjunctivitis — Feeling: Good · Be unable to work or attend schoolFree text: Got pink eye at daycare. Nothing related to the vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-31
- 2022-11-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-11-30 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): She had pain at injection site the day of their shot.
Release 10 — day 14, dose 2, dependent
Symptoms: Has a cold with runny nose and cough.
Release 11 — 3 months, dose 2, dependent
Symptoms: Got pink eye at daycare. Nothing related to the vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release